Medicine Supply Notification: Fixapost®, Vizilatan Duo®, Eysano® preservative free eye drops

The Department of Health and Social Care (DHSC) has issued a medicine supply notification (MSN) for:

  • Latanoprost 50micrograms/ml / Timolol 5mg/ml (Fixapost®) preservative free eye drops, 0.2ml unit dose.
  • Latanoprost 50micrograms/ml / Timolol 5mg/ml (Vizilatan Duo®) eye drops preservative free, 2.5 ml.
  • Timolol 2.5mg/ml and 5mg/ml (Eysano®) eye drops preservative free.

MSN/2026/054

Tier 2 – medium impact

Date of issue: 11 November 2026

  • Latanoprost 50micrograms/ml / Timolol [0.5%] 5mg/ml (Fixapost®) preservative free eye drops, 0.2ml unit dose, are out of stock until late November 2026.
  • Latanoprost 50micrograms/ml / Timolol [0.5%] 5mg/ml (Vizilatan Duo®) preservative free eye drops are out of stock until March 2027.
  • Timolol (Eysano®) 5mg/ml [0.5%] and 2.5mg/ml [0.25%] preservative free eye drops are out of stock until April 2027.
  • Latanoprost 50micrograms/ml / Timolol [0.5%] 5mg/ml eye drops (containing preservative) remain available and can support increased demand.
  • Timolol 0.25% and 0.50% eye drops (containing preservative) remain available and can support increased demand.
  • Latanoprost 50micrograms/ml (Monopost®) preservative free eye drops, 0.2ml unit dose, remain available and can support increased demand.
  • Timolol 1mg/g [0.1%] (Tiopex®) preservative free eye gel, 0.4g unit dose, remains available and can support increased demand.

A copy of this medicine supply notification, including supporting information, has been sent to all pharmacy NHS email addresses.

DHSC and NHS England have launched an online Medicines Supply Tool, which provides up-to-date information about medicine supply issues. The contents of these MSNs can now be viewed on the Tool.

The Tool also details any changes to resupply dates and updates to the entries.

To access the Tool you will need an NHS email address. Once set up and logged in, you will be able to access it online.

New shortages not listed on the SPS website, can be reported using our shortage reporting tool.

Know the current and upcoming community pharmacy regulatory changes.

Click Here